Arbutus Biopharma (ABUS) Amortizatization of Intangibles (2019 - 2026)

Arbutus Biopharma has disclosed Amortizatization of Intangibles across 8 years of filings, most recently posting $354000.0 for Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $354000.0, down 50.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.0 million (down 39.85% YoY), and the FY2025 annual result was $2.3 million, down 25.07% from the prior year.
• Amortizatization of Intangibles came in at $354000.0 for Q1 2026 at Arbutus Biopharma, down from $422000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $983000.0 in Q3 2024 to a low of -$168000.0 in Q1 2022.
• The 5-year median for Amortizatization of Intangibles is $541000.0 (2025), against an average of $475764.7.
• Across the five-year window, Amortizatization of Intangibles soared 743.37% in 2023 and plunged 54.28% in 2025, its largest moves.
• Arbutus Biopharma's Amortizatization of Intangibles stood at $224000.0 in 2022, then jumped by 176.34% to $619000.0 in 2023, then surged by 49.11% to $923000.0 in 2024, then slumped by 54.28% to $422000.0 in 2025, then fell by 16.11% to $354000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $354000.0 (Q1 2026), $422000.0 (Q4 2025), and $541000.0 (Q3 2025), per Business Quant data.